F369-0023 Screening compound: 4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

F369-0023 Screening compound: 4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one
F369-0023 Screening compound: 4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F369-0023
4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F369-0023

Molecular Formula

C24H22ClN3O2S2 (C24 H22 ClN3 O2 S2)

Compound Name

4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

IUPAC name

4-[2-(azepan-1-yl)-2-oxoethyl]-3-(4-chlorophenyl)-1-sulfanylidene-1H4H5H-[13]thiazolo[34-a]quinazolin-5-one

SMILES

O=C(CN(C(N1c2c3cccc2)=C(c(cc2)ccc2Cl)SC1=S)C3=O)N1CCCCCC1

InChI

InChI=1S/C24H22ClN3O2S2/c25-17-11-9-16(10-12-17)21-22-27(15-20(29)26-13-5-1-2-6-14-26)23(30)18-7-3-4-8-19(18)28(22)24(31)32-21/h3-4,7-12H,1-2,5-6,13-15H2

InChI Key

YRUFMWWUEXHHDZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14952033

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.04

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.037

Distribution Coefficient, logD

5.037

Water Solubility, LogSw

-5.12

Polar Surface Area

34.511

Acid Dissociation Constant (pKa)

25.68

Base Dissociation Constant (pKb)

1.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

F369-0023 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F369-0023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F369-0023?
Check Price and Availability of F369-0023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F369-0023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F369-0023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F369-0023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F369-0023 available by request